Valuation — not yet established
No valuation for Castle Creek Biosciences is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($419.4M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Castle Creek Biosciences
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2025 | Later Stage VC | $75.0M | ▮ | ▮ |
| Apr 2022 | Later Stage VC | $112.8M | ▮ | ▮ |
| Jan 2022 | Debt | $11.8M | ▮ | ▮ |
| Jun 2021 | Debt | $25.0M | ▮ | ▮ |
How Castle Creek Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Castle Creek Biosciences, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- How much has Castle Creek Biosciences raised?
- Castle Creek Biosciences has raised $419.4M in total funding across 4 recorded rounds.
- When did Castle Creek Biosciences last raise?
- Castle Creek Biosciences last raised in Feb 2025 (Later Stage VC), raising $75.0M.